(2020). Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19?
Chicago Style (17th ed.) CitationOutcome of Myeloma Patients with COVID-19 on Active Lenalidomide-based Therapy: Does Lenalidomide Protect from Severe COVID-19? 2020.
MLA (8th ed.) CitationOutcome of Myeloma Patients with COVID-19 on Active Lenalidomide-based Therapy: Does Lenalidomide Protect from Severe COVID-19? 2020.
Warning: These citations may not always be 100% accurate.